Comparing clinical perimetry and population receptive field measures in patients with choroideremia by Silson, Edward H. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comparing clinical perimetry and population receptive field
measures in patients with choroideremia
Citation for published version:
Silson, EH, Aleman, TS, Willett, A, Serrano, LW, Pearson, DJ, Rauschecker, AM, Maguire, AM, Baker, CI,
Bennett, J & Ashtari, M 2018, 'Comparing clinical perimetry and population receptive field measures in
patients with choroideremia', Investigative Ophthalmology & Visual Science, vol. 59, no. 8, pp. 3249-3258.
https://doi.org/10.1167/iovs.18-23929
Digital Object Identifier (DOI):
10.1167/iovs.18-23929
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Investigative Ophthalmology & Visual Science
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. Nov. 2019
Visual Neuroscience
Comparing Clinical Perimetry and Population Receptive
Field Measures in Patients with Choroideremia
Edward H. Silson,1 Tomas S. Aleman,2,3 Aimee Willett,2 Leona W. Serrano,2,3 Denise J. Pearson,2,3
Andreas M. Rauschecker,4 Albert M. Maguire,2,3 Chris I. Baker,1 Jean Bennett,2,3 and Manzar
Ashtari2–4
1Section on Learning and Plasticity, Laboratory of Brain and Cognition, National Institute of Mental Health, National Institutes of
Health, Bethesda, Maryland, United States
2Center for Advanced Retinal and Ocular Therapeutics (CAROT), University of Pennsylvania, Philadelphia, Pennsylvania, United
States
3F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania,
United States
4Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States
Correspondence: Manzar Ashtari,
University of Pennsylvania, Philadel-
phia, PA 19104, USA;
ashtari@pennmedicine.upenn.edu.
Submitted: January 24, 2018
Accepted: May 07, 2018
Citation: Silson EH, Aleman TS, Willett
A, et al. Comparing clinical perimetry
and population receptive field mea-
sures in patients with choroideremia.
Invest Ophthalmol Vis Sci.
2018;59:3249–3258. https://doi.org/
10.1167/iovs.18-23929
PURPOSE. Choroideremia (CHM) is an X-linked recessive form of hereditary retinal
degeneration, which, at advanced stages, leaves only small central islands of preserved
retinal tissue. Unlike many other retinal diseases, the spared tissue in CHM supports excellent
central vision and stable fixation. Such spared topography in CHM presents an ideal platform
to explore the relationship between preserved central retinal structure and the retinotopic
organization of visual cortex by using functional magnetic resonance imaging (fMRI).
METHODS. fMRI was conducted in four participants with CHM and four healthy control
participants while they viewed drifting contrast pattern stimuli monocularly. A single ~3-
minute fMRI run was collected for each eye separately. fMRI data were analyzed using the
population receptive field (pRF) modeling approach. Participants also underwent ophthalmic
evaluations of visual acuity and static automatic perimetry.
RESULTS. The spatial distribution and strength of pRF estimates correlated positively and
significantly with clinical outcome measures in most participants with CHM. Importantly, the
positive relationship between clinical and pRF measurements increased with increasing
disease progression. A less consistent relationship was observed for control participants.
CONCLUSIONS. Although reflecting only a small sample size, clinical evaluations of visual
function in participants with CHM were well characterized by the spatial distribution and
strength of pRF estimates by using a single ~3-minute fMRI experiment. fMRI data analyzed
with pRF modeling may be an efficient and objective outcome measure to complement
current ophthalmic evaluations. Specifically, pRF modeling may be a feasible approach for
evaluating the impact of interventions to restore visual function.
Keywords: choroideremia, retinotopy, fMRI, population receptive fields
Retinotopic mapping with functional magnetic resonanceimaging (fMRI) has been widely used to reveal the
systematic representation of visual space in the cerebral cortex
(for review see Ref. 1). During these scans, participants
typically fixate on the center of a screen while a visual stimulus
(e.g., high-contrast checkerboard) moves systematically
through the visual field, allowing for estimation of the preferred
retinotopic location of each voxel.2–4 Population receptive field
(pRF) modeling,5–7 an advanced method as compared to
standard retinotopic mapping paradigms, uses a computational
model of visual responses to provide an objective and efficient
estimate of the visual space over which the activity of each
voxel can be modulated.8 Although standard retinotopic
mapping and pRF modeling have been used primarily to study
the visual system of healthy volunteers with no history of ocular
disease, a number of studies have applied these techniques to
patients with ocular disease, primarily age-related macular
degeneration,9–11 but also glaucoma,12 retinitis pigmentosa,13
and patients with homonymous visual field deficits.14 In this
study, we applied pRF modeling to patients with choroideremia
(CHM).
CHM is an X-linked inherited form of retinal degenera-
tion.15–21 Patients typically present in the second decade of life
with nyctalopia (night blindness), followed by progressive
constriction of the visual field, while their central vision is
spared even into the sixth decade of life.22–29 This relatively
preserved central vision is subserved by islands of retinal tissue
that are separated from the surrounding blind retina by steep
transitions in the retinal structure, from a near normal
appearance to complete atrophy.22–29 The ‘‘geographic’’
topography of the retinal structure and associated vision in
this disorder offer a platform to explore the precise relation-
ships between the remaining central and peripheral vision and
the cortical representations of the visual field measured
through fMRI.
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The goal of this study was to assess the relationship
between the visual functions measured through standard static
automatic perimetry (SAP) and pRF estimates measured with
fMRI in a group of participants with CHM at different disease
stages.
METHODS
Subjects
Four patients with molecularly confirmed CHM (Table 1) and
four healthy control (HC) participants with normal ophthalmic
examinations were included in this study (for full patient
description see Supplementary Material and Supplementary
Fig. S1). All participants underwent a complete ophthalmic
examination and had their visual sensitivity measured with SAP.
Informed consent was obtained from individual participants
after explanation of the study procedures in compliance with
the Declaration of Helsinki. The study consent form was
approved both by the Children’s Hospital of Philadelphia and
the University of Pennsylvania Internal Review Board.
Retina Functional and Structural Measures
Achromatic, light-adapted SAP was performed with a modified
system Humphrey Field Analyzer (HFA II-i; Carl Zeiss Meditec,
Dublin, CA, USA) by using a conventional 10-2 testing protocol
grid (200-ms duration, 0.458 diameter, achromatic stimuli) and
a horizontal sensitivity profile that extended to 108 from
fixation (200-ms duration, 1.78 diameter stimuli) in light-
(achromatic stimuli) and dark-adapted (500-nm and 650-nm
stimuli) conditions.22,26,30 The lateral extent of the central
visual field was estimated by determining the eccentricity at
which cone-mediated sensitivities within this profile were
reduced to <5dB. Retinal imaging was performed with a
spectral-domain optical coherence tomography (SD-OCT;
Spectralis; Heidelberg Engineering, Carlsbad, CA, USA) system.
SD-OCT was performed with 9-mm-long horizontal sections
crossing the anatomical fovea.22
fMRI Parameters
fMRI scans were conducted at the Children’s Hospital of
Philadelphia on a research-dedicated 3.0T Siemens Verio
system (Erlangen, Germany) using a 12-channel head coil. All
scans were performed by a single operator and monitored to
be free of artifacts at the time of acquisition. PRF experiments
were performed using a blood-oxygenation-level-dependent
(BOLD) sequence, acquiring 100 volumes with 29 slices at 2.8
3 2.8 3 2.5-mm resolution (matrix, 64 3 64; repetition time
[TR]/echo time [TE], 2000/30 ms; flip angle, 908; field of view,
180 mm2 with total acquisition time of 3:24 minutes) in
oblique orientation perpendicular to calcarine sulcus. Four
brain volumes were acquired at the beginning of each fMRI
experiment to allow reaching T1 equilibrium and were not
used in the final analysis. pRF acquisitions were accomplished
using a real-time fMRI function to monitor subjects’ motion in
real time. Scans were terminated if a subject’s motion in three
translational and rotational directions exceeded 1 mm or 1
degree, respectively.31
Anatomic Imaging Parameters
A 3-D magnetization prepared rapid acquisition gradient echo
(MPRAGE) sequence was used to obtain high-resolution T1-
weighted anatomic scans with the following characteristics:
TR/TE, 2080/2.43 ms; bandwidth, 180 Hz/Px; matrix size, 256
3 256; field of view, 256 3 256 mm2; 192 axial slices; slice
thickness, 1 mm; inversion time, 1200 ms, with flip angle, 98;
number of excitations, 1; echo spacing, 7.3; integrated parallel
imaging techniques, 2; and scan time, 5.45 minutes.
pRF Mapping Stimulus
The pRF stimulus consisted of a bar within a circular aperture
with 100% contrast drifting checkerboards traversing through
the visual field. The bar stimuli made a total of 8 sweeps, with
12 evenly-spaced steps per sweep (1 step/TR). Specifically, the
order of eight sweeps for each run were as follows: (1) left –
right, (2) bottom right – top left, (3) top – bottom, (4) bottom
left – top right, (5) right – left, (6) top left – bottom right, (7)
bottom – top, and (8) top right – bottom left. The last six bar
positions on each of the four diagonal sweeps were occluded
to allow for baseline estimation.7 Bar stimuli were contained
within a circular aperture with a total diameter of 22.58. Each
participant completed two runs with either the left eye or right
eye occluded. Occlusion was controlled electronically via an
MRI-compatible goggle system, which allowed stimuli to be
presented to each eye separately. In each run, while
performing the pRF experiments, participants fixated monoc-
ularly on a small circular disk that appeared in the center of
their visual field and changed in color between red and green.
To ensure their central fixation and attention to the experi-
ment, subjects were asked to respond every time the small
circular disk in the center changed color by using an MRI-
compatible response device.
MRI Data Preprocessing
All pRF data were analyzed using the Analysis of Functional
NeuroImages (AFNI) software package32 (provided in the
public domain by the National Institutes of Health, Bethesda,
MA, USA; http://afni.nimh.nih.gov/afni). Images were prepro-
cessed to control for subject motion (3dvolreg) by using the
TABLE 1. Clinical and Molecular Characteristic of Patients
Patient
Identification Age, y
REP1
Mutation
Visual Acuity
(ETDRS)
Foveal
Sensitivity, dB*
Field
Extent, deg† EZ Extent, mm‡
Foveal
Thickness, lm
RE LE RE LE RE LE RE LE RE LE
P1 37 c.745del. T 20/20 20/20 36 37 29 28 5.7 6.9 253 267
P2 22 EX3_9del 20/20 20/25 36 37 16 14 2.6 3.4 264 271
P3 26 p.Lys234* 20/20 20/25 35 35 14 11 3.2 3.4 251 213
P4 63 p.Arg270* 20/40 20/32 29 25 10 8 0.8 1.7 179 175
RE, right eye; LE, left eye.
* Normal mean 6 2SD¼ 36 6 6 dB.
† From a light-adapted, central (630 deg) horizontal, sensitivity profile to a Goldmann size V target.
‡ Extent of uninterrupted ellipsoid zone (EZ) band extent.
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first volume of the first run as a reference, after removing the
first four volumes to establish equilibrium. After motion-
correction, images were detrended (3dDetrend, removing
second-order polynomial trends) and smoothed (3dmerge)
with a 5-mm full-width at half-maximum Gaussian kernel.
Given that a single ~3-minute run was acquired per eye, time
series data were smoothed to boost signal-to-noise. Notably,
unsmoothed time series were also analyzed and did not change
the overall pattern of results and the correlations between
clinical and pRF measurements.
pRF Analysis
All pRF analyses were conducted in AFNI by using a pRF
implementation for the AFNI distribution, developed by
Richard Reynolds.33 For every voxel in the brain, the model
initially estimates the center of the pRF on an x, y grid with 200
samples across both the height and width of the field of view.
For each point in the grid, the sizes of pRFs (sigma) are
sampled at the same resolution but over a default range of 0 to
half the field of view (sampled at 100 even intervals). These
default parameters result in four million possible pRFs (with
unique x, y location and size). Given the position of the
stimulus in the visual field at every TR, the estimated time
series for a receptive field of a given location and size is
modeled. The model then makes use of a 2-D stimulus time
series, which contains binary masks of the stimulus location at
each TR and a convolution with a standard hemodynamic
response function to produce four million predicted time
series. Both Simplex and Powell optimization algorithms are
used simultaneously to find the best time series/parameter sets
(x, y, and size [sigma]) by minimizing the least-squares error of
the predicted time series measured against the acquired time
series in each voxel. The model outputs for each voxel include
the estimated diameter for the pRFs (size/sigma), along with
the x, y locations representing the center of the pRF, and the
corresponding explained variance (R2) for the fit, which can be
used to statistically threshold these data.
Visual Field Coverage
The visual field coverage maps were computed individually for
all participants (controls and patients). These maps were
derived from all voxels, with an explained variance >20%.
Each voxel’s pRF was plotted as a scaled 2-D Gaussian onto a
matrix representing the visual field. Once all pRFs were
overlaid, the maximum explained variance (across voxels) was
calculated for every position in the visual field (pixel of the
matrix).14,33 To normalize visual field coverage plots across all
participants, these values were divided by the maximum
explained variance that was present in one of the HC
participants (HC1).
Surface Reconstructions
Surface reconstructions of the gray and white matter boundary
of individual hemispheres for each participant were made
using the Freesurfer4 autorecon script (provided in the public
domain, http://surfer.nmr.mgh.harvard.edu/) and visualized
using the Surface Mapping with AFNI (SUMA) software
package.
RESULTS
Clinical Characterization of CHM
The CHM patients enrolled in this study (Table 1) exemplify
different extents of relative histologic preservation at a stage of
the disease when this otherwise predominantly midperipheral
disease reaches the central retina (Fig. 1). On infrared
reflectance (NIR-REF) imaging, the patient with the mildest
abnormalities (patient 1, P1) shows a lighter region near the
optic nerve, with a scalloped contour (Fig. 1A, yellow dotted
line). The rest of the central retina has a normal NIR-REF
appearance. An SD-OCT cross section through the foveal center
shows a normal lamination pattern in most of the scan (Fig. 1B).
Nasal to the fovea, coinciding with the boundary between
normal and hyperreflective NIR-REF signal, there is a transition
zone (TZ) of abrupt changes in thickness and organization of the
retinal layers. There is an orderly loss of structures with
increasing distance from the fovea: first, there is loss of the
signal that originates from the interdigitation zone between the
photoreceptor outer segment tips and the apical retinal pigment
epithelium (RPE), followed by attenuation and loss of the zone
of transition between the photoreceptor inner segment and the
photoreceptor outer segment or ellipsoid zone, and ending with
thinning and loss of the outer nuclear layer. Nasal to the TZ (Fig.
1B, P1, arrow), increased deep backscattering of the SD-OCT
signal caused by RPE depigmentation and/or loss (Fig. 1B, P1,
asterisk) precedes a region of total chorioretinal atrophy.
Colocalized light-adapted sensitivity profiles are normal across
most of the length of the scan, except for localized loss within
and nasal to the TZ (Fig. 1B). The rectangular grid of the
standard 10-2 SAP protocol was used to determine the
topographic distribution of the sensitivity losses across the
central 108 field in the patients (Fig. 1A, C). A sensitivity map
shows a dense (‡50-dB loss) scotoma at ~68 in nasal retina that
corresponds to the TZ of structural change. Severe sensitivity
loss at this location is surrounded by retina with normal or near-
normal light-adapted sensitivity, a common feature in CHM.
With disease progression, the centripetal movement of the TZs
leaves residual geographic islands of relative preservation of the
NIR-REF signal and underlying structure on SD-OCT, surrounded
by chorioretinal atrophy (Figs. 1, P2–P4). Even at these stages,
cone-mediated vision may be near normal at the foveal center
but transitions abruptly to a blind atrophic retina. The associated
topography of the remaining central visual field matches the
shape of the residual islands on NIR-FAF (Figs. 1A,C). In every
example, the disease ‘‘dissects’’ out regions of relative structural
and functional preservation from the surrounded blind retina.
The pattern presents a unique platform in which to explore the
relationships between the topography of the retinal structure
and function and its cortical representation by fMRI.
Visual Field Coverage From pRF Modeling
To compare clinical and pRF measurements for each CHM and
HC participant, we initially computed visual field coverage
maps from all significantly modulated voxels (>20% explained
variance), pooled across both hemispheres. The inclusion of
voxels from both hemispheres matches the SAP measurements,
as both hemispheres process visual signals from each eye.
Visual field coverage maps represent the maximum pRF
value at each location in the visual field and are displayed for
the left eye data of each CHM participant and a representative
HC participant (HC1) in Figure 2 (See Supplementary Fig. S2
for the right eye data). These visual field coverage maps clearly
depict a more restricted peripheral visual field, with the
presence of a more centralized vision in CHM participants (Fig.
2). The strength of peripheral representations reflects the
various disease stages in this sample of CHM participants, with
the weakest peripheral representations observed for partici-
pants in mid- to late-stage disease (e.g., P3, P4). In particular,
P4, with end-stage disease, exhibits only central visual field
representations and little or no contribution from more
peripheral locations.
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pRF Visual Field Coverage Maps Correlate with SAP
Measurements in CHM
To quantify the relationship between SAP and pRF measure-
ments, visual field coverage maps were spatially resampled to
match the SAP measurements (see Supplementary Material).
The SAP and resulting modified pRF visual field coverage maps
for the left eye of each CHM participant and a representative
control (HC1) are displayed in Figure 3. Visual inspection of
Figure 3 demonstrates clear similarities between the SAP and
pRF measurements for CHM participants, with similar heat
map intensity patterns for cells occupying largely commensu-
rate locations. For instance, in P4, the highest SAP and pRF
values are located at the very center of the visual field in both
FIGURE 1. Central retinal structural and functional changes in the patients. (A) NIR-REF images of the central retina. Images are 3083 308 centered
at the fovea (F). Horizontal green arrows show the position and direction of the SD-OCT scans; overlaid yellow arrow in P1 shows a 6-mm segment
used for correlation between SD-OCT and function in B. Dotted yellow line demarcates a pale area of chorioretinal atrophy near the optic nerve
head (ONH) that is surrounded by retina with a grossly normal NIR-REF appearance. Overlaid grid of red circles shows the position and size of the
visual stimuli (n¼ 68) used to test the sensitivity of the central retina with the 10-2 protocol in C. Scale bar at bottom. (B) Shown are 6-mm-long
horizontal SD-OCT cross sections from temporal (T) through the fovea into nasal (N) retina in the four CHM patients. Scans cover region shown
with horizontal yellow arrow in A. Nuclear layers (outer nuclear layer, ONL; inner nuclear layer, INL; ganglion cell layer GCL) are labeled in the
temporal retina of P1, which shows a normal retinal architecture. Outer photoreceptor/RPE laminae are numbered (1, outer limiting membrane; 2,
inner segment/outer segment region or ellipsoid zone (EZ); 3, interdigitation zone (IZ) between photoreceptor outer segment tips and the apical
RPE; 4, RPE/Bruch’s membrane [RPE/BrM]). Arrow points to a region closest to the fovea where there is loss of the IZ signal (or photoreceptor outer
segment tip), which signals the beginning of a transitional zone (TZ) of increasing structural abnormalities with increasing eccentricity from the
foveal center. Apteryx points to region of increased backscattering of the SD-OCT signal caused deeper penetration of the signal through
depigmented RPE outside of the TZ. Bars above the scans show psychophysically determined light-adapted sensitivities along a horizontal profile
that colocalizes with the region scanned with SD-OCT. Dotted lines above bars define the lower limit (normal mean, 2 SD) of the sensitivity
estimates. T, temporal retina; N, nasal retina. Calibration bar to the bottom left. (C) Central visual field sensitivities measured with automated light-
adapted static threshold perimetry and a conventional system and clinical protocol (Humphrey Field Analyzer; 10-2 protocol). Maps extend to 108 of
eccentricity and are flipped vertically to match the corresponding retinal position of the test grid on the NIR-REF images. Raw sensitivity estimates
are plotted as gray scale maps (bottom of column); black areas represent absolute scotomas to this testing protocol (sensitivities 0 dB), lighter
areas represent better (>30 dB) sensitivities.
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measurements (Fig. 3, top right). Similarly, the lower left
quadrant of the visual field and the right visual field contain
both the highest SAP and pRF values in P2 and P3, respectively
(Fig. 3, bottom).
The Pearson’s correlation between the two measurements
was computed for each CHM and HC participant and is
displayed for both the left and right eyes of P3 in Figure 4,
along with the SAP and modified pRF visual field coverage
maps. As shown in Figure 4, significant and positive
correlations between SAP and pRF measurements were
observed for both the left (r ¼ 0.46, P < 0.0001) and right (r
¼ 0.58, P < 0.0001) eyes in P3. Indeed, positive and significant
relationships between SAP and pRF measurements were
present in all but two cases (P1, right eye and P2; right eye)
among CHM participants. In contrast, HCs showed limited
consistency in the relationship between SAP and pRF
measurements (Table 2).
pRF Strength Across Eccentricity Reflects Clinical
Eccentricity Profiles
To quantify the relationship between clinical and pRF
eccentricity profiles, visual field coverage maps were spatially
resampled to match the spatial sampling of clinical assessments
(see Supplementary Material). The clinical and resampled pRF
eccentricity profiles for the left eye of each CHM participant
and a representative control (HC1) are displayed in Figure 5. As
shown in Figure 5, clinical and pRF eccentricity profiles show
strikingly similar patterns in mid (P2, P3) and late (P4) stage
CHM participants, with lower sensitivity (poorer vision/lower
pRF value) at eccentric positions in both nasal and temporal
fields and a sharp rise in sensitivity (better vision/higher pRF
value) toward the center of the visual field (eccentricity, 08).
The similarity in eccentricity profiles is particularly clear for P4
with end-stage disease. In both measurements, sensitivity
FIGURE 2. Left eye pRF visual field coverage maps for four CHM participants and one HC (HC1). To compare the results with individual clinical
assessments, visual field data were restricted toþ108 and108 of the entire visual field. These plots represent the maximum pRF coverage at each
position in the visual field and were derived from all significantly modulated voxels (>20% explained variance), pooled across both hemispheres.
The total number of included voxels is inset onto each map. As shown in the center image, the visual field coverage for a typical HC (HC1) exhibits
high pRF values (hot colors) across the visual field except at the extreme upper and lower vertical meridians. Coverage plots for CHM participants
are presented relative to the maximum pRF intensity in HC1. As shown here, P1, who had relatively preserved peripheral and central vision,
presented with a similar pRF distribution to HC1, albeit patchier and with slightly reduced intensity. Unlike P1, P4 was at a more advanced stage of
disease progression, with much more restricted peripheral vision and much smaller preserved central vision. The visual field coverage for P4 is
strikingly different from HC1 as well as P1. The two remaining CHM participants (P2 and P3) represent mid-stage disease, and the pRF visual field
coverage for these CHM participants are also strikingly different from that of HC1. However, both of these CHM participants show greater degrees of
central and peripheral vision as compared with the pRF distribution for P4. P2 showed relatively high pRF values in the upper left and lower right
quadrants of the visual field, whereas P3 showed a strong central representation extending further into the lower visual field and a markedly
reduced representation of the periphery.
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values are largely flat across eccentricity, apart from a sharp
rise at the center of the visual field (Fig. 5, top right).
The Pearson’s correlation between the two measurements
of horizontal eccentricity was computed separately for the left
and right eyes for each CHM and HC participant. An example
of the correlation results for P3 is shown in Figure 6. We
observed highly significant positive correlations between
clinical and pRF eccentricity profiles for the left (r ¼ 0.90, P
< 0.0001) and right (r ¼ 0.86, P < 0.0001) eyes in P3. The
strong positive relationship between clinical and pRF eccen-
tricity profiles was also present for both the left and right eyes
of P2 and P4, but not P1 who was at an early disease stage (see
Table 3 for statistical breakdown). In contrast to the CHM
participants, HCs presented with clinical eccentricity profiles
that were, for the most part, flat across the entire extent of the
tested central visual field, which likely contributes to the
largely nonsignificant and inconsistent relationships between
clinical and pRF eccentricity profiles across HCs (Supplemen-
tary Fig. S4).
FIGURE 3. Total deviation SAP and modified pRF visual field coverage maps for the left eye data from all patients and a representative HC (HC1). In
each case, the modified pRF visual field coverage maps are displayed as heat maps to the left. These visual field coverage maps have been normalized
to the maximum value within the modified visual field coverage map of HC1. Positions in the visual field with higher pRF values are color-coded as
yellow/white, with positions in the visual field with lower pRF values color-coded as red/black. The right-hand plot in each case depicts the total
deviation SAP measurements as heat maps. In these plots, bright cells (yellow/white) represent locations in the visual field with sensitivity either
equal to or greater than normal age-matched controls, whereas dark-colors (red/maroon) represent locations in the visual field with decreased
sensitivity relative to a normal age-matched control. The black-line on the color bar represents the same sensitivity as a normal age-matched control.
Thus, bright yellow/white cells indicate increased sensitivity and orange/red/maroon cells indicate decreased sensitivity.
TABLE 2. Pearson’s Correlation Values Between SAP and pRF
Measurements and Corresponding P values for the Left and Right Eyes
of Both Patients and HCs
Participant
Identification
Left Eye Right Eye
Pearson’s r P Value Pearson’s r P Value
P1 0.31 <0.01 0.16 ns
P2 0.24 <0.05 0.15 ns
P3 0.46 <0.001 0.58 <0.001
P4 0.56 <0.01 0.26 <0.05
HC1 0.05 ns 0.27 <0.05
HC2 0.29 <0.05 0.05 ns
HC3 0.33 <0.01 0.16 ns
HC4 0.34 <0.01 0.29 <0.01
ns, P > 0.05.
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DISCUSSION
The peculiar topography of the visual field and the depth of the
sensitivity loss of patients with CHM in this study were well
represented in the spatial distribution and strength of pRF
estimates. Importantly, the strength of this positive relationship
increased with increasing stages of disease progression.
Indeed, this positive relationship was most prominent in
CHM participants at moderately advanced or late disease stages
and was either less consistent or not present in HCs or
participants at the earliest stages of disease progression,
respectively.
Links between visual function, as measured clinically with
SAP, and cortical representations, as measured through fMRI34
and specifically pRFs,14 have been reported for patients with
cortical lesions.14 and in patients with Leber’s congenital
amaurosis following retinal gene therapy.31 This study used
CHM as a disease model of photoreceptor degeneration and
demonstrated strong positive relationships between SAP and
pRF measurements. The current data are consistent with many
previous fMRI studies of diverse patient populations10,14,34–35
that have similarly demonstrated a link between clinical
measures of visual function and cortical responses measured
with fMRI.
Previous work has used fMRI36–38 and, in particular, pRF
modeling11 to investigate potential mechanisms of foveal
reorganization in patients with macular degeneration, with
reports both for36–38 and against11 the technique. Here, the
focus was on demonstrating the relationship between the
clinical measures of visual function and cortical representa-
tions of the visual field in patients with CHM and not on
potential mechanisms of cortical reorganization39 caused by
disease. The potential for cortical reorganization in CHM
patients is, however, an important topic that should be the
focus of future studies, especially given the existing evidence
of retinal remodeling in CHM as well as the somewhat unusual
longevity of high levels of fine spatial discrimination in this
condition.22,29
Significant and positive correlations were observed be-
tween clinical and pRF eccentricity profiles in all but one CHM
participant (P1 left and right eyes) who was at an early disease
stage. Thus, as compared to other CHM participants who were
at later stages of disease progression, P1 presented with near-
normal horizontal eccentricity profiles (See Supplementary Fig.
S4). As such, similarly to HC participants, the correlations
between SAP and pRF measurements in P1 could have been
highly affected by the lack of variation in visual field sensitivity.
In all other CHM cases, strong positive correlations were
FIGURE 4. Pearson’s correlation between clinical and pRF measurements for both eyes in P3. As shown on the left, the mean pRF values for each
cell location is presented on the y-axis and the corresponding total deviation value, taken from the SAP, is shown on the x-axis. For ease of visual
comparison, the calculated pRF and total deviation heat-maps are shown along the ‘‘Y’’ and ‘‘X’’ axes, respectively. The Pearson’s correlations
between these two measures are plotted for all 68 cells for the left and right eye separately. Significant positive correlations were observed between
the SAP and pRF measures for both the left (r ¼ 0.46; P < 0.0001) and the right (r ¼ 0.58; P < 0.0001) eye, demonstrating strong associations
between the two measures of visual function in P3.
TABLE 3. Pearson’s Correlation Values Between Clinical and pRF
Eccentricity Profiles and Corresponding P values for the Left and Right
Eyes of Patients and HCs
Participant
Identification
Left Eye Right Eye
Pearson’s r P Value Pearson’s r P Value
P1 0.07 ns 0.18 ns
P2 0.60 <0.05 0.68 <0.01
P3 0.90 <0.001 0.86 <0.001
P4 0.88 <0.01 0.87 <0.01
HC1 0.10 ns 0.43 ns
HC2 0.73 <0.01 0.55 <0.05
HC3 0.16 ns 0.04 ns
HC4 0.41 ns 0.67 <0.05
ns, P > 0.05.
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observed, demonstrating that the strength of pRFs as a
function of horizontal eccentricity strongly predicts the
sensitivity of vision at those same eccentricities measured
clinically. The lack of consistent positive correlations between
clinical and pRF measurements in P1 and in all HCs may reflect
a ceiling effect in both measurements. For instance, the range
of SAP values across HCs (15; max, 4; min,11) was less than
half of the range across participants with CHM (41; max, 5;
min, 36). The second analysis, which focused on visual
sensitivity as a function of horizontal eccentricity, is also likely
affected by a similar ceiling effect. The sensitivity profiles of
the HCs, as measured herein with a relatively large (0.458
diameter) achromatic stimulus, were mainly flat across the
entire width of the tested visual field, with a maximum range of
only 6 dBs (Supplementary Fig. S4). Such constant sensitivity
across the visual field likely impacted the ability to observe
consistent and significant correlations in the HCs. The visual
field stimuli used in this work was intended to match protocols
commonly used in the clinic. However, in mildly affected early-
stage patients and HCs, this model may not adequately
represent the variation within the visual field to produce a
more sensitive relationship with the pRF measures. The steep
transitions in retinal tissue and visual function expressed in
CHM patients at mid- and late-disease stages, likely contribute
to the ability of the pRF method to better identify such
variability. As such, the pRF methodology may be less suited for
detection of early-stage disease in patients with slow retinal
degeneration.
Data from pRF estimates, which can be acquired in a single
~3-minute fMRI session, may provide additional objective
information for the functional evaluation of patients with
inherited retinal degenerations, particularly for those that
cause sharp transitions in visual function, such as CHM.
Notably, previous studies14,40 have suggested that pRF
estimates can be biased when a predictable stimulus is used
such as in this study. However, to the extent that any bias is
present in our data would only serve to reduce the correlation
between SAP and pRF measurements and cannot explain the
positive correlations that were observed. Moreover, these data
provide compelling evidence for the feasibility of using pRF
estimates as efficient and objective outcome measures for
investigating potential cortical effects of interventions to
FIGURE 5. Clinical and pRF horizontal eccentricity profiles for the left eye of all CHM participants and a representative HC (HC1). In each case, the
pRF derived horizontal eccentricity is plotted to the left, with the clinically derived visual sensitivity plotted to the right. Across all plots, horizontal
position (deg) is plotted on the x-axis, with the nasal (N) and temporal (T) visual fields labeled. For pRF profiles, the pRF value at that position is
plotted on the y-axis, normalized to the maximum pRF value within HC1. For clinical profiles, visual sensitivity (dB) is plotted on the y-axis.
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restore vision, such as retinal gene therapy. The current data
demonstrate the supportive role that pRF estimates can play in
complimenting patients’ ophthalmic examinations. The advan-
tages of using pRFs as complementary outcome measures are
that they are efficient and objective estimates of visual
sensitivity that accurately reflect brain function. All existing
pRF models output, for each voxel in the brain, a series of
parameter estimates whose values are interpretable with
respect to the tested visual field. The importance of fMRI
and, in particular, pRF measurements may be amplified when
used in conjunction with ongoing clinical assessments of
interventions to restore vision, such as retinal gene thera-
py.34,41–42 Indeed, studies assessing the effect of retinal gene
therapy on visual function in patients with CHM41–42 report
improved rod and cone functions accompanied with a gain in
visual acuity of the treated eye that correlated with the vector
dose administered. This improvement in visual function was
also reported in two patients at 3.5-years posttreatment.42 It
remains to be seen whether pRF measurements are sensitive
enough to detect any visual function improvements following
retinal gene therapy interventions.
CONCLUSIONS
Although reflecting only a small sample size, results from this
report demonstrate that pRF estimates in the visual cortex
correlate positively and significantly with clinical measures of
visual function in patients with CHM. In particular, pRF
measurements accurately mapped the topography of the field
of vision in CHM. Most importantly, the strength of the
correlation between clinical and pRF measurements increased
with disease severity. Unlike most CHM participants, HCs
presented with inconsistent correlations between clinical
assessments and pRF measures, which likely reflect ceiling
effects in both measurements. This preliminary study shows
the potential use of pRF estimates as an objective tool
complementary to clinical measures of vision and to explore
the consequences that retinal degenerations and their treat-
ments have on visual processing beyond the retina and into the
brain.
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